Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer
Open Access
- 1 February 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (11) , 17862-17872
Abstract
Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancerKeywords
This publication has 38 references indexed in Scilit:
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and ContextJNCI: Journal of the National Cancer Institute, 2009
- Regulatory effects of ferritin on angiogenesisProceedings of the National Academy of Sciences, 2009
- Elevation of Serum Ferritin is Associated with the Outcome of Patients with Newly Diagnosed Multiple MyelomaThe Korean Journal of Internal Medicine, 2009
- Prostate-specific antigen and prostate cancer: prediction, detection and monitoringNature Reviews Cancer, 2008
- Does excess iron play a role in breast carcinogenesis? an unresolved hypothesisCancer Causes & Control, 2007
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per MilliliterNew England Journal of Medicine, 2004
- Gleason grading and prognostic factors in carcinoma of the prostateLaboratory Investigation, 2004
- Increased serum ferritin in chronic liver disease: A risk factor for primary hepatocellular carcinomaInternational Journal of Cancer, 1989
- Value of Serum Alpha-Fetoprotein and Ferritin in the Diagnosis of Hepatocellular CarcinomaOncology, 1986